Kennedy Announces New Cost-Saving Drug Plan – KXL

WASHINGTON, DC – The White House is announcing another plan meant to lower the cost of prescription drugs in the U.S.  On Wednesday, Health and Human Services Secretary Robert F. Kennedy, Jr. announced said the Food and Drug Administration will be making it easier for ” biosimilars” to enter U.S. markets, something Europe has been doing for decades. Biosimilars are drugs similar to those that have been proven to work and have already been approved by the FDA.

“This is a victory for patients, for innovation, and commonsense,” Kennedy told reporters. “In Europe, for example, regulators have approved more than twice as many biosimilars as the United States,” he added.

Kennedy says he is cutting the red tape, and clinical trials that are necessary before these types of drugs can be sold in the U.S.